First, Regulations Amending the Food and Drug Regulations (1528 — Schedule F):
1. The reference to
Botulinum Toxin Type A
Antitoxine botulinique, Type A
in Part I of Schedule F to the Food and Drug Regulations… is replaced by the following:
Botulinum toxin Type A
Toxine botulinique, type A
2. Part I of Schedule F to the Regulations is amended by adding the following in alphabetical order:
Alglucosidase alfa
Alglucosidase alfa
Darunavir
Darunavir
Natalizumab
Natalizumab
Rasagiline and its salts
Rasagiline et ses sels
Sorafenib and its salts
Sorafénib et ses sels
Tigecycline
Tigécycline
Second, Regulations Amending the Food and Drug Regulations (1541 — Schedule F):
1. The reference to
Diclofenac and its salts
Diclofénac et ses sels
in Part I of Schedule F to the Food and Drug Regulations… is replaced by the following:
Diclofenac and its salts, except when sold as a single medicinal ingredient in a concentration equivalent to 1% or less diclofenac in preparations for topical use on the skin
Diclofénac et ses sels sauf s’ils sont vendus comme ingrédient médicinal unique en une concentration maximale de 1 % dans les préparations pour usage topique sur la peau
Nexreg Compliance